Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Lung Capacity01:47

Lung Capacity

56.3K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.3K
Gene Therapy00:59

Gene Therapy

27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Group Therapy01:26

Group Therapy

433
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
433
Behavior Therapy01:22

Behavior Therapy

702
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
702

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytisine for Smoking Cessation Within a Lung Cancer Screening Program: Results From the Italian RISP Trial.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

From Ascites to Malignant Peritoneal Mesothelioma: The Diagnostic Workup of a Rare Tumor.

Cancer diagnosis & prognosis·2026
Same author

Durvalumab plus etoposide-platinum in patients with epidermal growth factor receptor (EGFR)-mutated advanced NSCLC and neuroendocrine transformation after first-line osimertinib: ORCHARD.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Corrigendum to 'Patient-Reported Outcomes With Consolidation Durvalumab Versus Placebo After Concurrent Chemoradiotherapy in Limited-Stage SCLC: Results From the Phase 3 ADRIATIC Trial' [Journal of Thoracic Oncology volume 21 issue 6 (2026) 103564].

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway.

Cancer discovery·2026
Same author

The antibiotic-immunotherapy interaction in NSCLC: a systematic review and meta-analysis of 54,250 patients across three outcomes.

Cancer treatment reviews·2026
Same journal

Correction.

Lung cancer management·2026
Same journal

Surgical management of concomitant lung cancer and cardiovascular diseases: a multidisciplinary perspective.

Lung cancer management·2026
Same journal

Cost-effectiveness analysis of tepotinib vs capmatinib as subsequent therapy in MET exon 14-mutated non-small-cell lung cancer.

Lung cancer management·2026
Same journal

Addition of pulsed electric field ablation to SBRT for lung tumors: effect on health-related quality of life.

Lung cancer management·2026
Same journal

CyberKnife radical cure for early lung adenocarcinoma: a case was confirmed by postoperative pathology.

Lung cancer management·2026
Same journal

Cost of managing brain metastases in ALK-positive advanced NSCLC patients receiving first-line ALK TKIs in China.

Lung cancer management·2026
See all related articles

Related Experiment Video

Updated: Jan 30, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K

Interview: developing therapies for lung cancer.

Silvia Novello1

  • 1Department of Oncology, San Luigi Hospital, University of Turin, Orbassano, Turin, Italy.

Lung Cancer Management
|January 16, 2019
PubMed
Summary
This summary is machine-generated.

Professor Silvia Novello is a leading expert in thoracic oncology and lung cancer research. Her work focuses on diagnosis, treatment, and understanding gender differences in lung cancer.

More Related Videos

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.2K
Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
08:45

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring

Published on: November 13, 2012

14.3K

Related Experiment Videos

Last Updated: Jan 30, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.2K
Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
08:45

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring

Published on: November 13, 2012

14.3K

Area of Science:

  • Medical Oncology
  • Thoracic Malignancies
  • Lung Cancer Research

Background:

  • Silvia Novello is a Full Professor of Medical Oncology at the University of Turin.
  • She heads the Thoracic Oncology Unit at San Luigi Hospital, Orbassano, Italy.
  • Her expertise spans medical and postgraduate education in respiratory medicine and medical oncology.

Purpose of the Study:

  • To highlight Professor Novello's extensive research interests in thoracic malignancies.
  • To emphasize her contributions to primary prevention and gender differences in lung cancer.
  • To showcase her involvement in clinical trials for novel lung cancer diagnosis and therapy.

Main Methods:

  • Extensive clinical trial involvement.
  • Focus on basic and applied research in lung cancer.
  • Exploration of pharmacogenomics in lung cancer treatment.

Main Results:

  • Over 100 publications in peer-reviewed journals.
  • Significant leadership roles in international and national lung cancer associations.
  • Active participation in scientific committees for lung cancer research foundations.

Conclusions:

  • Professor Novello is a key figure in advancing lung cancer research and treatment.
  • Her work addresses critical areas such as prevention, gender disparities, and innovative therapies.
  • She is dedicated to improving outcomes for patients with thoracic malignancies.